UNSPSC 41202102: Analyte specific reagents

In this classification Analyte specific reagents are antibodies, both polyclonal and monoclonal, specific receptor proteins, ligands, nucleic acid sequences, and similar reagents which, through specific binding or chemical reaction with substances in a specimen, are intended for use in a diagnostic application for identification and quantification of an individual chemical substance or ligand in biological specimens. US FDA regulates Analyte specific reagents under 21 CFR 864.4020 and under FDA product code MVU.

UNSPSC 41202102 Analyte specific reagents is a Commodity code covering diagnostic test reagents and kits that state and local governments procure to support public health, clinical laboratory, and criminal justice testing operations. Recent solicitations show state and local buyers acquiring HIV rapid test kits, sexually transmitted infection testing reagents (gonorrhea/chlamydia), syphilis testing kits, and drug testing supplies for screening and confirmation assays. The issuing bodies include state health departments (Illinois Department of Public Health), county health services and community supervision departments (Collin County, Texas), city public health agencies (Austin), and county corrections or criminal justice systems (Gwinnett County, Georgia). Illinois Department of Public Health and Collin County, Texas appear as repeat buyers across multiple opportunities in the recent posting window.

Recent activity spans Texas, Illinois, and Georgia. The Illinois Department of Public Health posted a change order in late September 2026 to increase annual Hologic NG/CT testing volumes from 15,000 to 25,000 tests and collection kits from 15,000 to 30,000 units under a five-year reagent rental agreement, raising contract cost by $375,000 to a revised total of $900,000 (IFB 27482DPHOFCDIB53956, response due October 13, 2026). Collin County Community Supervision and Corrections Department issued an RFP for offender specimen collection and drug testing services covering approximately 25,031 annual tests (immunoassay screening with LC/MS/MS or GC/MS confirmation), with responses due July 23, 2026 and an estimated contract value of $600,000. Austin issued an IFB for rapid HIV 1/2 test kits and controls (Abbott Determine line) to supply the Public Health Program at approximately 375 test kits and 79 control kits annually (IFB 9100 AAM1023 REBID, response due September 3, 2026). Illinois also conducted emergency sole-source procurements to Abbott Laboratories for HIV and Syphilis reagents for IDPH's Carbondale Laboratory analyzer systems, totaling $38,079.50.